Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001995218-25-000003

Chief Executive Officer acquired 2,193 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Townsend Richard Nolan · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-09-12 Grant or award : show line 1 in the form +2,193 $2.64 $5,798 222,251 D
Loading xslF345X05/form4-09162025_050903.xml…